Table 10.
Variable | SMD | SE | 95% CI | P-value | R 2 | I 2, % | τ2 |
---|---|---|---|---|---|---|---|
Multiple implants, % of studies (KH) | 0.215 | 0.051 | 0.114 to 0.315 | 0.001 | 20.4 | 47.4 | 0.035 |
Stimulation (reference not stimulated) | |||||||
Stimulated (KH) | 0.084 | 0.088 | −0.089 to 0.257 | 0.654 | |||
Not stated (KH) | 0.237 | 0.092 | 0.057 to 0.419 | 0.035 | |||
Multiple implants, % of studies (robust experiment level) | −0.030 | 0.069 | −0.380 to 0.320 | 0.852 | 0.001 | ||
Multiple implants, % of studies (robust treatment level) | 0.461 | 0.175 | 0.312 to 0.890 | 0.039 | |||
Stimulation (reference not stimulated) | |||||||
Stimulated (robust experiment level) | 0.128 | 0.162 | −0.288 to 0.544 | 0.465 | |||
Not stated (robust experiment level) | 0.241 | 0.196 | −0.244 to 0.725 | 0.267 |
The estimates based on Knapp–Hartung (KH) methods provide a SMD, SE, and 95% CI of the SMD, significance (P-value), model fit (R2), and measures of heterogeneity I2 and τ2. The estimates based on robust regression methods (robust) at the experiment and treatment level provide a SMD, SE, and 95% CI of the SMD, P-value, and τ2.